Ls Investment Advisors, LLC Lantheus Holdings, Inc. Transaction History

Ls Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$11.98 - $16.34 $32,501 - $44,330	-2,713 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$10.34 - $15.51 $14,507 - $21,760	1,403 Added 107.1%	2,713 $39,000
Q1 2019 Apr 25, 2019	BUY	$14.93 - $25.1 $2,986 - $5,020	200 Added 18.02%	1,310 $32,000
Q4 2018 Feb 01, 2019	SELL	$12.68 - $19.01 $21,695 - $32,526	-1,711 Reduced 60.65%	1,110 $17,000
Q3 2018 Nov 13, 2018	SELL	$13.1 - $16.35 $2,646 - $3,302	-202 Reduced 6.68%	2,821 $42,000
Q1 2018 May 08, 2018	BUY	$14.85 - $24.3 $2,747 - $4,495	185 Added 6.52%	3,023 $48,000
Q4 2017 Feb 07, 2018	SELL	$17.4 - $23.4 $112,543 - $151,351	-6,468 Reduced 69.5%	2,838 $58,000
Q3 2017 Oct 19, 2017	BUY	$15.5 - $19.15 $144,243 - $178,209	9,306	9,306 $166,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.21B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.